336 related articles for article (PubMed ID: 15830252)
21. Input analysis for two public consultations on the EU Clinical Trials Regulation.
Langhof H; Lander J; Strech D
Health Res Policy Syst; 2016 Sep; 14(1):69. PubMed ID: 27639695
[TBL] [Abstract][Full Text] [Related]
22. Reforming the EU environment for clinical trials: what are the challenges?
Fears R; Blum HE; Kelleher D; Meunier F; Souhami R
QJM; 2013 Sep; 106(9):787-9. PubMed ID: 23893498
[No Abstract] [Full Text] [Related]
23. [Reorganization of the procedures and the tasks of the responsible ethics committees after the 12th AMG amendment. Concepts of the permanent working group of the medical ethics committees in Germany].
Wessler I; Burger R; Doppelfeld E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):155-67. PubMed ID: 15726456
[TBL] [Abstract][Full Text] [Related]
24. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
Grienenberger A
J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
[TBL] [Abstract][Full Text] [Related]
25. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
Beattie S;
Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
[TBL] [Abstract][Full Text] [Related]
26. The development of good clinical practice in the EEC and in Germany.
Anhalt E
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258
[TBL] [Abstract][Full Text] [Related]
27. [Consequences of the 12th AMG amendment on the conduct of non-commercial clinical trials].
Rossion I
Urologe A; 2005 Dec; 44(12):1444-8. PubMed ID: 16283155
[TBL] [Abstract][Full Text] [Related]
28. Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries.
Hartmann M
Trials; 2012 Apr; 13():53. PubMed ID: 22540886
[TBL] [Abstract][Full Text] [Related]
29. EU directive on clinical trials penalizes small sponsors.
Meldolesi A
Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
[No Abstract] [Full Text] [Related]
30. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173
[TBL] [Abstract][Full Text] [Related]
31. [Approval of clinical trials with biological medicinal products].
Gross S; Jost N; Hartmann JP
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):826-829. PubMed ID: 28677049
[TBL] [Abstract][Full Text] [Related]
32. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of SUSARs. Clinical evaluation of single cases in terms of regulatory requirements].
Wroblewski H; Schmickler M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):459-63. PubMed ID: 15830258
[TBL] [Abstract][Full Text] [Related]
34. [The implementation of European directives into national law, demonstrated by the example of the EC Tissues and Cells Directive 2004/23/EC].
von Auer F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):757-63. PubMed ID: 18563281
[TBL] [Abstract][Full Text] [Related]
35. Status of the GCP guidelines in Europe.
Geussenhainer S
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
[TBL] [Abstract][Full Text] [Related]
36. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
Bilbault P; Belorgey C; Zannad F; Golinelli D; Pletan Y;
Therapie; 2010; 65(4):301-8, 291-9. PubMed ID: 20854751
[TBL] [Abstract][Full Text] [Related]
37. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
Ramirez I
Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
Renner M; Anliker B; Sanzenbacher R; Schuele S
Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
[TBL] [Abstract][Full Text] [Related]
39. [The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].
Henn DK; Ruppert T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):28-37. PubMed ID: 36449064
[TBL] [Abstract][Full Text] [Related]
40. Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations.
Lehmann B
Child Adolesc Psychiatry Ment Health; 2008 Dec; 2(1):37. PubMed ID: 19063722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
